CN1323589A - 一种治癌消瘤中药 - Google Patents
一种治癌消瘤中药 Download PDFInfo
- Publication number
- CN1323589A CN1323589A CN 00106689 CN00106689A CN1323589A CN 1323589 A CN1323589 A CN 1323589A CN 00106689 CN00106689 CN 00106689 CN 00106689 A CN00106689 A CN 00106689A CN 1323589 A CN1323589 A CN 1323589A
- Authority
- CN
- China
- Prior art keywords
- gram
- grams
- medicine
- restrains
- tumor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 24
- 239000003814 drug Substances 0.000 title claims abstract description 17
- 201000011510 cancer Diseases 0.000 title claims abstract description 15
- 239000004863 Frankincense Substances 0.000 claims abstract description 9
- 241000180649 Panax notoginseng Species 0.000 claims abstract description 9
- 235000003143 Panax notoginseng Nutrition 0.000 claims abstract description 9
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 239000009636 Huang Qi Substances 0.000 claims description 8
- 241000283956 Manis Species 0.000 claims description 8
- 241000195474 Sargassum Species 0.000 claims description 8
- 241000131808 Scolopendra Species 0.000 claims description 8
- 229940126678 chinese medicines Drugs 0.000 claims description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 210000000582 semen Anatomy 0.000 claims description 8
- 239000010356 tongguan Substances 0.000 claims description 8
- 241000131329 Carabidae Species 0.000 claims description 7
- 241000241125 Gryllotalpa gryllotalpa Species 0.000 claims description 7
- 241000255626 Tabanus <genus> Species 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 claims description 4
- 235000019634 flavors Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 11
- 210000004369 blood Anatomy 0.000 abstract description 11
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 4
- 244000144730 Amygdalus persica Species 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000009138 Curcuma zedoaria Species 0.000 abstract 1
- 235000003405 Curcuma zedoaria Nutrition 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000208682 Liquidambar Species 0.000 abstract 1
- 235000006552 Liquidambar styraciflua Nutrition 0.000 abstract 1
- 235000006040 Prunus persica var persica Nutrition 0.000 abstract 1
- 241000270666 Testudines Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 239000001812 curcuma zedoaria berg. rosc. Substances 0.000 abstract 1
- 230000003467 diminishing effect Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 210000005260 human cell Anatomy 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 231100000915 pathological change Toxicity 0.000 abstract 1
- 230000036285 pathological change Effects 0.000 abstract 1
- 239000000843 powder Substances 0.000 abstract 1
- -1 sofflower Substances 0.000 abstract 1
- 235000019509 white turmeric Nutrition 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 7
- 210000001015 abdomen Anatomy 0.000 description 6
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 206010000077 Abdominal mass Diseases 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 208000005718 Stomach Neoplasms Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000036461 convulsion Effects 0.000 description 2
- 206010017758 gastric cancer Diseases 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 230000002175 menstrual effect Effects 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 201000011549 stomach cancer Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 208000013452 Fallopian tube neoplasm Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000736919 Pelodiscus sinensis Species 0.000 description 1
- 229920001231 Polysaccharide peptide Polymers 0.000 description 1
- 206010043966 Tongue neoplasm malignant stage unspecified Diseases 0.000 description 1
- 206010046798 Uterine leiomyoma Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 201000002266 mite infestation Diseases 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920001184 polypeptide Chemical class 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 108010022457 polysaccharide peptide Proteins 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 108090000765 processed proteins & peptides Chemical class 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种新的治癌消瘤中药,该中药由桃仁、黄芪、海藻、莪术、红花、乳香、重蝼、枳实、甲珠、土鳖、蜈蚣、虻虫、半枝莲、路路通、三七、通关散、甘草十四味中药,混合炒炙熟后研磨成粉而得。具有活血化瘀、治癌固本、软坚散结、消炎止痛的功效,能使人体病变细胞故缩后,从各个分泌系统排出体外,达到治愈的目的。
Description
本发明属于治癌消瘤的中医中药技术领域。
癌症是当今医学界的一大难治之症，医学界为攻克这一医学难题而不懈努力，在不断的研究中，每一个技术成果的取得，都推动着治癌技术的进步，为最终战胜癌症奠定基础。在现有技术中关于治癌消瘤方面的中医中药种类很多，各种中药配方不同，作用和功效也各有不同。
本发明的目的是提供一种新药，专用于治癌消瘤。
实现本发明发明目的的技术方案是：提供一种新的治癌消瘤中药，该中药由桃仁、黄芪、海藻、莪术、红花、乳香、重蝼、枳实、甲珠、土鳖、蜈蚣、虻虫、半枝莲、路路通、三七、通关散、甘草十四味中药，混合炒炙熟后研磨成粉而得。
服用时每曰三次，每次6克，三十天为一个疗程。
根据各类中医中药书中对上述中药配方中各种成份的记载：桃仁具有活血祛痰，润肠通便的作用，可治闭经痛经、症瘕痞块、跌打损伤、肠燥便秘；黄芪具有补气固表，托毒排浓，利尿生肌的作用，可治气虚乏力、久泻脱肛、自汗、水肿、子宫脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合；海藻含褐藻酸、甘露醇、马尾藻、多糖及多肽类成份，有抑制癌症的作用；甘草有补脾益气、清热解毒祛痰止咳调和诸药的作用，用于脾胃虚弱、倦怠无力，心悸气短、咳嗽痰多、缓解药物毒性；莪术具有破血行气，消积止痛的作用，作于血瘀腹痛、肝脾肿大、血瘀闭经、饮食积滞；红花具有活箅通经、散瘕止痛的作用，用于经闭痛经、恶露不行、症瘕痞块、跌打损伤；乳香能活血祛瘀、消炎止痛作用，有行气作用；重楼有清热解毒、消肿止痛、凉肝定惊作用，用于疗肿消肿、咽喉肿痛，毒虫叮咬、跌打伤痛、惊风抽搐；枳实具有化痰散痞，破气消积的作用，用于积滞内停、痞满肚痛、泻痢后重、大便不通、痰滞气阻、胸痹；甲珠有治疥癞痈毒，破气行血的作用，能治瘢瘕积聚；上鳖有抗癌、抑制白血病患的白细胞的作用，能抑制肝癌、胃癌细胞的呼吸，用于子宫肌瘤、卵巢及输卵管肿瘤、肝癌、舌癌、胃癌等；蜈蚣功能破血化瘀主治症瘕积聚、蓄血等；半技莲功能清热解毒、化瘀利尿，主治疗疮肿毒、咽喉肿痛、毒蛇咬伤、跌打损伤、水肿、黄疸等。路路通功能祛风活络、利水通经，用于关节痹痛，麻木痉挛、水肿胀满；三七功能有散瘀止血、消肿定痛，用于种种内外出血，胸腹刺痛、跌打肿痛；通关散功能通乳利尿、活血生肌清热解毒消炎止痛。
上述十四味中药组合后，具有活血化瘀、治癌固本、软坚散结、消炎止痛的功效，能使人体病变细胞故缩后，从各个分泌系统排出体外，达到治愈的目的。
实施例一：在1000克该中药中各组成成份的含量分别为：
桃仁35克、黄芪50克、海藻50克、莪术85克、红花35克、乳香35克
重蝼35克、枳实50克、甲珠65克、土鳖100克、蜈蚣16克、虻虫14克
半枝莲70克、路路通85克、三七120克、通关散135克、甘草20克。
实施例二：在1000克该中药中各组成成份的含量分别为：
桃仁100克、黄芪85克、海藻85克、莪术160克、红花70克、乳香70克
重蝼63克、枳实50克、甲珠35克、土鳖35克、蜈蚣10克、虻虫7克、
半枝莲35克、路路通50克、三七50克、通关散85克、甘草10克。
实施例三：在1000克该中药中各组成成份的含量分别为：
桃仁40克、黄芪60克、海藻55克、莪术100克、红花45克、乳香45克
重蝼70克、枳实85克、甲珠70克、土鳖100克、蜈蚣17克、虻虫13克
半枝莲50克、路路通60克、三七75克、通关散100克、甘草15克。
实施例四：在1000克该中药中各组成成份的含量分别为：
桃仁60克、黄芪70克、海藻70克、莪术105克、红花50克、乳香50克
重蝼50克、枳实70克、甲珠55克、土鳖55克、蜈蚣14克、虻虫11克、
半枝莲50克、路路通70克、三七105克、通关散100克、甘草15克。
Claims (2)
1、一种治癌消瘤中药，由几味中药混合炒炙熟后研磨成粉而得，其特征在于：该药由桃仁、黄芪、海藻、莪术、红花、乳香、重蝼、枳实、甲珠、土鳖、蜈蚣、虻虫、半枝莲、路路通、三七、通关散、甘草几味中药制成。
2、如权利要求1所述的治癌消瘤中药，其特征在于：
在1000克该中药中各组成成份的含量分别为：
桃仁(35～100)克、 黄芪(50～85)克、 海藻50～85)克、
莪术(85～160)克、 红花(35～70)克、 乳香(35～70)克、
重蝼(35～70)克、 枳实(50～85)克、 甲珠(35～70)克、
土鳖(35～100)克、 蜈蚣(10～17)克、 虻虫(7～14)克、
半枝莲(35～70)克、 路路通(50～85)克、 三七(50～120)克、
通关散(85～135)克、 甘草(10～20)克。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00106689 CN1323589A (zh) | 2000-05-17 | 2000-05-17 | 一种治癌消瘤中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00106689 CN1323589A (zh) | 2000-05-17 | 2000-05-17 | 一种治癌消瘤中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1323589A true CN1323589A (zh) | 2001-11-28 |
Family
ID=4578415
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00106689 Pending CN1323589A (zh) | 2000-05-17 | 2000-05-17 | 一种治癌消瘤中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1323589A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101138612B (zh) * | 2006-10-13 | 2011-12-07 | 桂林商源植物制品有限公司 | 一种抗肿瘤制剂及其制备方法 |
-
2000
- 2000-05-17 CN CN 00106689 patent/CN1323589A/zh active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101138612B (zh) * | 2006-10-13 | 2011-12-07 | 桂林商源植物制品有限公司 | 一种抗肿瘤制剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN108619473A (zh) | 一种治疗糖尿病周围神经病变的中药熏洗剂 | |
| CN105213974A (zh) | 一种治疗淋巴瘤的中药组合物及其应用 | |
| CN101297940A (zh) | 一种治疗肿瘤和癌症病的药物及配制方法 | |
| CN102940808A (zh) | 一种用于治疗肺癌的组方药物及制备方法 | |
| CN103330872B (zh) | 一种蛇伤康复药的制备方法 | |
| CN103330873B (zh) | 一种蛇伤康复药 | |
| CN105288069A (zh) | 癌症穴位止痛膏剂的制备方法 | |
| CN1323589A (zh) | 一种治癌消瘤中药 | |
| CN102091267B (zh) | 一种治疗寻常型银屑病的药物及其制备方法 | |
| CN104958474A (zh) | 一种治疗湿热郁阻型胰腺癌的中药及其制备方法 | |
| CN100371016C (zh) | 采取分期治疗乳腺病的中药制剂 | |
| CN102764275A (zh) | 一种治疗肿瘤的外用中药及其制备方法 | |
| CN103071104B (zh) | 一种治疗中晚期胰腺癌的中药复方制剂 | |
| CN103251779B (zh) | 专治猪冻伤的中药药膏 | |
| CN112402565B (zh) | 一种治疗膝关节滑膜炎的中药组合物及其制备方法 | |
| CN101167915B (zh) | 治疗慢性浅表性胃炎的中药组合物及其制备方法 | |
| CN1861119B (zh) | 治疗风湿病的中药及其制法 | |
| CN100353995C (zh) | 一种具有祛风活络解毒的药物组合物 | |
| CN101579487A (zh) | 一种治疗筋骨的胶囊 | |
| CN105012789A (zh) | 治疗宫颈癌的组合物及其制备方法 | |
| CN101024029A (zh) | 一种治疗骨性关节炎、风湿性关节炎的药物 | |
| CN104758749A (zh) | 一种治疗肝癌的中药组合物 | |
| CN104645196A (zh) | 一种治疗癌痛的中药配方 | |
| CN111000950A (zh) | 一种扶正散结抗肿瘤的中药组合物 | |
| CN103386036B (zh) | 一种治疗红白痢疾的药物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: NONE Free format text: FORMER OWNER: WU QINGGEN Effective date: 20030618 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20030618 Address after: 655000 Gate No. 40, Dongmen street, Yunnan, Qujing Applicant after: Li Jiankun Address before: 655000 Gate No. 40, Dongmen street, Yunnan, Qujing Applicant before: Li Jiankun Co-applicant before: Wu Qinggen |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |